Differentially expressed growth factors and cytokines drive phenotypic changes in transmissible cancers
Discovery Immunology · 20.01.2025 · 4 (1)
DOI: 10.1093/discim/kyaf011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discovery Immunology, online erschienen am 12.07.2025. Verfasst von Kathryn G Maskell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Tasmania Advancement Office, Save the Tasmanian Devil Appeal, Select Foundation Research Fellowship.
Abstract (Originalsprache)
Introduction
The Tasmanian devil is threatened by two deadly transmissible Schwann cell cancers. A vaccine to protect Tasmanian devils from both devil facial tumour 1 (DFT1) and devil facial tumour 2 (DFT2), and improved understanding of the cancer cell biology, could support improved conservation actions.
Methods
Previous transcriptomic analysis has implicated phenotypic cellular plasticity as a potential immune escape and survival mechanism of DFT1 cells. This phenotypic plasticity facilitates transition from a myelinating Schwann cell to a repair Schwann cell phenotype that exhibits mesenchymal characteristics. Here, we have identified cytokines and growth factors differentially expressed across DFT cell phenotypes and investigated their role in driving phenotypic plasticity and oncogenic properties of DFT cells.
Results
Our results show that NRG1, IL16, TGFβ1, TGFβ2, and PDGFAA/AB proteins have significant and distinct effects on the proliferation rate, migratory capacity and/or morphology of DFT cells. Specifically, PDGFR signalling, induced by PDGFAA/AB, was a strong enhancer of cell proliferation and migration, while TGFβ1 and TGFβ2 induced epithelial-mesenchymal transition (EMT)-like changes, inhibited proliferation and increased migratory capacity.
Conclusion
These findings suggest complex interactions between cytokine signalling, phenotypic plasticity, growth and survival of DFTs. Signalling pathways implicated in the propagation of DFT are potential targets for therapeutic intervention and vaccine development for Tasmanian devil conservation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.
- Institute for Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria.
- Agriculture and Food, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Tasmania, Australia.
ORCID-Profile: Kathryn G Maskell, Anna Schönbichler, Andrew S Flies, Amanda L Patchett
Förderung
- University of Tasmania Advancement Office
- Save the Tasmanian Devil Appeal
- Select Foundation Research Fellowship
- Tall Foundation
- Australian Research Council
Zitieren
APA
Maskell, K. G., Schönbichler, A., Flies, A. S., & Patchett, A. L. (2025). Differentially expressed growth factors and cytokines drive phenotypic changes in transmissible cancers. Discovery Immunology, 4(1). https://doi.org/10.1093/discim/kyaf011
Vancouver
Maskell KG, Schönbichler A, Flies AS, Patchett AL. Differentially expressed growth factors and cytokines drive phenotypic changes in transmissible cancers. Discovery Immunology. 2025;4(1). doi:10.1093/discim/kyaf011
BibTeX
@article{Maskell2025,
author = {Maskell, Kathryn G and Schönbichler, Anna and Flies, Andrew S and Patchett, Amanda L},
title = {Differentially expressed growth factors and cytokines drive phenotypic changes in transmissible cancers},
journal = {Discovery Immunology},
year = {2025},
volume = {4},
number = {1},
doi = {10.1093/discim/kyaf011}
}
EUVIMED